Biopharmaceutical Contract Biomanufacturing Market, (4th Edition), 2020-2030 by Roots Analysis

Driven by several blockbuster products, a burgeoning pipeline and the need for dedicated expertise in the myriad of technical nuances associated with biomolecules, the biopharmaceutical contract manufacturing market has a lucrative future

 


Roots Analysis is pleased to announce the publication of its recent study, titled, “Biopharmaceutical Contract Biomanufacturing Market, (4th Edition), 2020-2030.”

 

The report features an extensive study on the contract service providers within the biopharmaceutical industry. The study features in-depth analyses, highlighting the capabilities of a diverse set of biopharmaceutical CMOs and contract development and manufacturing organizations (CDMOs). Amongst other elements, the report includes:

§  A detailed review of the overall landscape of companies offering biopharmaceutical contract manufacturing services.

§  A detailed landscape of the biopharmaceutical manufacturing facilities established across the key geographical regions.

§  Elaborate profiles of key players that claim to have a diverse range of capabilities related to the development, manufacturing and packaging of biologics.

§  A detailed discussion on the key enablers in this domain, including certain niche product classes, such as antibody drug conjugates (ADCs), bispecific antibodies, cell therapies, gene therapies and viral vectors.

§  A case study on the growing global biosimilars market, highlighting the associated opportunities for biopharmaceutical CMOs and CDMOs.

§  A case study comparing the key characteristics of small and large molecule drugs, along with details on the various steps involved in their respective manufacturing processes.

§  A detailed discussion on the overview, benefits and challenges associated with in-house manufacturing.

§  A qualitative analysis, highlighting the various factors that need to be taken into consideration by biopharmaceutical therapeutics / drug developers while deciding whether to manufacture their respective products in-house or engage the services of a CMO.

§  An analysis of the initiatives of big biopharma players engaged in this domain.

§  An analysis of the recent collaborations, mergers and acquisitions and expansions that have been established in this domain, in the recent past.

§  An analysis of the recent developments within the biopharmaceutical contract manufacturing industry.

§  A detailed capacity analysis, taking into consideration the individual development and manufacturing capacities of various stakeholders engaged in this domain.

§  An informed estimate of the annual demand for biologics based on several parameters.

§  A discussion on affiliated trends, key drivers and challenges, under an elaborate SWOT framework.

§  A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing contract manufacturing services to biopharmaceutical  developers.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

§  Commonly outsourced business operations

§  API

§  FDF

 

To order this 780+ page report, which features 300+ figures and 270+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/biopharmaceutical-contract-manufacturing-market/250.html

 

 

 

§  Types of Expression Systems Used

§  Mammalian

§  Microbial

§  Others

 

§  Scale of Operation

§  Preclinical / Clinical

§  Commercial

 

§  Company Size

§  Small

§  Mid-sized

§  Large / Very Large

 

§  Types of Biologics Manufactured

§  Antibody Therapeutics

§  Vaccines

§  Cell Therapies

§  Other Biologics

 

§  Key Geographical Regions

§  North America

§  Europe

§  Asia-Pacific

§  Latin America

§  Middle East and North Africa

 

To request a sample copy / brochure of this report, please visit this - https://www.rootsanalysis.com/reports/250/request-sample.html

 

 

Key companies covered in the report

§  AGC Biologics

§  Boehringer Ingelheim

§  Catalent

§  Cytiva (GE Healthcare)

§  FUJIFILM Diosynth Biotechnologies

§  KBI Biopharma

§  Kemwell Biopharma

§  Lonza

§  Luina Bio

§  Novasep

§  Olon

§  Patheon

§  Piramal Pharma Solutions

§  Takara Bio

§  WuXi AppTec (WuXi Biologics)

 

For additional details, please visit 

https://www.rootsanalysis.com/reports/view_document/biopharmaceutical-contract-manufacturing-market/250.html or email sales@rootsanalysis.com

 

You may also be interested in the following titles:

1.     Vaccine Contract Manufacturing Market (3rd Edition), 2021-2030

2.     ADC Contract Manufacturing Market (4th Edition), 2020-2030

3.     Microbial Contract Manufacturing Market, 2020-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

 

Contact Details 

Ben Johnson 

+1 (415) 800 3415 

ben.johnson@rootsanalysis.com 

 

Roots Analysis 

Web: https://www.rootsanalysis.com/ 

LinkedIn: https://in.linkedin.com/company/roots-analysis 

Twitter: https://twitter.com/RootsAnalysis.com 

Medium: https://medium.com/@RootsAnalysis 

Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/ 

Quora: https://rootsanalysisinsights.quora.com/ 

Comments

Post a Comment

Popular posts from this blog

Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 by Roots Analysis

Image
With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious op            timism. In fact, recent studies suggest that mesenchymal stem cells have the potential to end the Coronavirus (COVID-19) pandemic .   Roots Analysis is pleased to announce the publication of its recent study, titled, “ Global Stem Cells Market : Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow, Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, Neural Tissue Placenta, Peripheral Blood, Stromal Cells); and Potency (Multipotent, Pluripotent)) ”.   The   report features an extensive study of the curre...
Read more

Cannabis market Professional Survey Report by 2035

  Cannabis Market Forecast to 2035 The Global Cannabis Market Report is a comprehensive report on the Cannabis market, offering key insights on business strategies, current trends, and presenting qualitative and quantitative analysis of the Cannabis market. This report offers in-depth research insights on key and significant aspects of the Cannabis market, providing an in-depth analysis of key drivers, restraints, restraints, growth prospects, threats, and risks. The report also includes an in-depth analysis of the competitive landscape and regional scope of the Cannabis market. The global Cannabis market report employs an extremely extensive and perceptive process that analyzes statistical data relating to services and products offered in the market. The research study is a pivotal document in understanding the needs and wants of the clients. The report is comprised of significant data about the leading companies and their marketing strategies. The Cannabis industry is witnes...
Read more

The ophthalmic drugs contract manufacturing market is estimated to be worth USD 1.7 billion in 2030, predicts Roots Analysis

Image
  Outsourcing has become a popular trend among ophthalmic drug developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages Roots Analysis is pleased to announce the publication of its recent study, titled, “ Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms (Ophthalmic Drops, Emulsions, Gels, Injections, Lotions, Ointments, Suspensions, and Tablets / Capsules), 2020-2030 . ”   The report features an extensive study of the contract services market for ophthalmic products and solutions. It features in-depth analyses, highlighting the capabilities of a diverse set of CMOs and CDMOs. Amongst other elements, the report includes: §   A detailed review of the ophthalmic drugs contract manufacturing market landscape, featuring a list of over 240 CMOs and analysis based on a number of relevant parameters. ...
Read more